β¨ Medicine Distribution Consents
4096 NEW ZEALAND GAZETTE, No. 164 2 DECEMBER 2010
Product:
Noradrenaline Tartrate
Active Ingredient:
Noradrenaline acid tartrate monohydrate 0.199g/L equivalent to 0.1g noradrenaline base
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Biomed Limited
Manufacturer:
Biomed Limited, Auckland, New Zealand
Note: This consent is valid for two years from the date of publication of this notice.
Product:
Noradrenaline Tartrate
Active Ingredient:
Noradrenaline acid tartrate monohydrate 0.239g/L equivalent to 0.12g noradrenaline base
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Biomed Limited
Manufacturer:
Biomed Limited, Auckland, New Zealand
Note: This consent is valid for two years from the date of publication of this notice.
Product:
Noradrenaline Tartrate
Active Ingredient:
Noradrenaline acid tartrate monohydrate 0.319g/L equivalent to 0.16g noradrenaline base
Dosage Form:
Solution for infusion
New Zealand Sponsor:
Biomed Limited
Manufacturer:
Biomed Limited, Auckland, New Zealand
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 26th day of November 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go9226
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Cefazolin-AFT
Active Ingredient:
Cefazolin sodium 540mg equivalent to 500mg cefazolin
Dosage Form:
Powder for injection
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Medochemie Limited, Limassol, Cyprus
Product:
Cefazolin-AFT
Active Ingredient:
Cefazolin sodium 1.08g equivalent to 1g cefazolin
Dosage Form:
Powder for injection
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Medochemie Limited, Limassol, Cyprus
Product:
Cerezyme
Active Ingredient:
Imiglucerase-rch 400U
Dosage Form:
Powder for infusion
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:
Genzyme Ireland Limited, Waterford, Ireland
Bionique Testing Laboratories, Saranac Lake, United States of America
BioReliance Testing and Development, Incorporated, Rockville, United States of America
Product:
Ibuprofen Liquid Capsules
Active Ingredient:
Ibuprofen 200mg
Dosage Form:
Liquid filled capsule
New Zealand Sponsor:
Multichem NZ Limited
Manufacturer:
Geltec Private Limited, Bangalore, India
Product:
Ismo 40 Retard
Active Ingredient:
Isosorbide mononitrate 40mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Kern Pharma SL, Barcelona, Spain
Product:
Naltraccord
Active Ingredient:
Naltrexone hydrochloride 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Accord Healthcare NZ Limited
Manufacturer:
Intas Pharmaceuticals Limited, Ahmedabad, India
Next Page →
β¨ LLM interpretation of page content
π₯
Provisional Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare26 November 2010
Medicines, Provisional Consent, Noradrenaline Tartrate, Biomed Limited
- JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines, Consent, Cefazolin-AFT, Cerezyme, Ibuprofen Liquid Capsules, Ismo 40 Retard, Naltraccord
NZ Gazette 2010, No 164